Company Data
Longeveron Inc.
Ticker
LGVN
Current Price
$1.68
Market Cap
$4.2M
Price Target
Refer to Report
Volume
9.3K
52wk Range
$1.6 - $44
Overview
Longeveron Inc is a biotechnology company developing cellular therapies for specific ageing-related and life-threatening conditions. It is involved in sponsoring clinical trials in the following indications: Aging Frailty, Alzheimer’s disease, the Metabolic Syndrome, Acute Respiratory Distress Syndrome (ARDS), and Hypoplastic left heart syndrome (HLHS).